Simulect Use In Pregnancy & Lactation

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Use In Pregnancy & Lactation

Simulect is contraindicated during pregnancy and lactation. Basiliximab has potentially hazardous pharmacological effects with respect to the course of gestation and the suckling neonate exposed to basiliximab in breast milk. This concern is based on basiliximab's immunosuppressive action. Women of childbearing potential must use adequate contraception to prevent pregnancy and continue its use for an additional 8 weeks after the last dose of Simulect.

Simulect Use In Pregnancy & Lactation

basiliximab

Manufacturer:

Novartis Indonesia